Form 8-K - Current report:
SEC Accession No. 0001213900-24-097495
Filing Date
2024-11-13
Accepted
2024-11-13 16:30:09
Documents
13
Period of Report
2024-11-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0221050-8k_citius.htm   iXBRL 8-K 27683
  Complete submission text file 0001213900-24-097495.txt   202005

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ctxr-20241106.xsd EX-101.SCH 3027
3 XBRL LABEL FILE ctxr-20241106_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ctxr-20241106_pre.xml EX-101.PRE 22367
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0221050-8k_citius_htm.xml XML 3677
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 241454821
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)